1. Agurell, S., J. Dahmén, H. Edery, K. Leander, and R. Mechoulam (1975) Synthesis and biological activity of side chain hydroxylated tetrahydrocannabinols. (To be published.)
2. Agurell, S., S. Levander, M. Binder, A. Bader-Bartfai, B. Gustafsson, K. Leander, J.-E. Lindgren, A. Ohlsson, and B. Tobisson (1975) Pharmacokinetics of Δ8-tetrahydrocannabinol in man after smoking —relations to physiological and psychological effects. The Pharmacology of Cannabis (M. Braude and S. Szara, eds.). Baltimore: University Park Press.
3. Binder, M., S. Agurell, K. Leander, and J.-E. Lindgren (1974) Zur identification potentieller metabolite von cannabis inhaltstoffen: kernresonanz und massenspektroskopische Untersuchungen an seiten-kettenhydrozylierten cannabinoiden. Helv. Chim. Acta57:1626.
4. Burstein, S., J. Martinez, J. Rosenfeld, and T. Wittstruck (1972) The general pharmacology of cannabinoids. Cannabis and Its Derivatives. (W. D. M. Paton, and J. Crown, eds.). London: Oxford University Press, pp. 39–49.
5. Burstein, S. H. (1973) Labeling and metabolism of the tetrahydrocannabinols. Marijuana (R. Mechoulam, ed.). New York: Academic Press, pp. 167–190.